Our Strategy

Our investment objective is absolute returns with an effort to be tax efficient.

Learn more about our approach to our combination of growth and opportunity in the medical technology sector, driven by our unique perspectives and proven track record.

We monitor a universe of 300 public healthcare companies and invest in a select few. The majority are in the field of medical technology with the remainder in healthcare services lab tools and diagnostics. We have a long-bias. We tend to avoid companies with high valuations or that do not have approved products and revenues.